← Back to Search

Nonsteroidal Anti-inflammatory Drug

Ketorolac for Acute Pain

Phase 4
Waitlist Available
Led By Benjamin W Friedman, MD
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two hours
Awards & highlights

Study Summary

This trial will compare how effective ketorolac and ibuprofen are for people with acute moderate or severe musculoskeletal pain. The investigators will also determine whether taking acetaminophen prior to the NSAID impacts efficacy.

Eligible Conditions
  • Acute Pain
  • Musculoskeletal Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two hours after medication administration
This trial's timeline: 3 weeks for screening, Varies for treatment, and two hours after medication administration for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Failure to achieve a minimum clinically important difference
Secondary outcome measures
0-10 pain score
Epigastric pain
Ordinal pain scale

Trial Design

2Treatment groups
Active Control
Group I: KetorolacActive Control1 Intervention
Ketorolac 20mg orally x 1
Group II: IbuprofenActive Control1 Intervention
Ibuprofen 800mg orally x 1

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterLead Sponsor
441 Previous Clinical Trials
581,789 Total Patients Enrolled
14 Trials studying Acute Pain
28,242 Patients Enrolled for Acute Pain
Benjamin W Friedman, MDPrincipal InvestigatorMontefiore Medical Center
2 Previous Clinical Trials
449 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research currently enrolling participants?

"Affirmative. By perusing clinicaltrials.gov, it is evident that this medical study has resumed its search for appropriate participants since June 1st 2022 and was recently updated on August 3rd 2022. The trial seeks to enrol 400 individuals at a single research facility."

Answered by AI

How many participants are currently being considered for this experiment?

"Affirmative. According to information on clinicaltrials.gov, this research venture has been open for recruitment since June 1st 2022 and recently updated on August 3rd 2022. The project is currently enrolling 400 participants at a single site."

Answered by AI

Who is authorized to participate in this research?

"This clinical trial is intended for those with acute pain seeking treatment and are aged between 18 to 69 years of age. 400 patients need to be recruited in total."

Answered by AI

Is the drug Ketorolac authorized by the FDA?

"The safety rating of Ketorolac is a 3, as it has been approved by the FDA and thus there are multiple rounds of data supporting its efficacy."

Answered by AI

Is this research open to participants of advanced age?

"Patiens with ages that exceed 18 years old and are below the age of 69 can participate in this medical trial."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Randomized Trial of NSAID Dosing Strategies
2022. "A Randomized Trial of NSAID Dosing Strategies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05239767.
~144 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top